VEGF-C has been shown to reduce lymphedema by stimulating lymphangiogenesis33, 34, 60, and its binding to VEGFR-3 has been recently reported to alter the intrinsic and phasic pumping of collecting LVs31. The gene discussed is FLT4; the disease is lymphedema.